FIELD: biotechnology.
SUBSTANCE: invention relates to a biodegradable synthetic polymer, namely to the polymer of the general formula (I) , where NA has the structure: , AN has the structure: , where n is an integer >2; Z is either absent or is an amino acid residue -NH-(CH2)i-CO-, where i - is an integer from 1 to 5; D represents a linear or branched alkyl C1-C5 or benzyl; B represents a residue of aliphatic diamine -NH-(CH2)k-NH-, where k is an integer from 2 to 6; X and Y can simultaneously have the following meanings: X=H-B, Y=H, or X=Nα-(D-OCO)-L-arginyl-Z-B, Y=Nα-(D-OCO)-L-arginyl-Z, or X=R1-AN-B, Y=NA-R1, where R1 is carboxamide-alkyl of the type H2NCO-CH2- or H2NCO-CH2CH2-. Such a polymer is capable of delivering the natural L-arginine into the tissues of human, animals, through biological membranes and can be used alone or in a combination with other active compounds.
EFFECT: invention enables to obtain the polymer soluble in water, which has no cytotoxicity and enhances the level of nitrogen oxide in the tissues of humans and animals.
2 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
PEPTIDE HAVING NEUROTROPIC ACTIVITY | 2008 |
|
RU2394836C2 |
HEMIN DERIVATIVES, HAVING ANTIMICROBIAL ACTIVITY OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, SYNTHESIS METHOD, PHARMACEUTICAL COMPOSITION AND USE | 2009 |
|
RU2415868C1 |
PROTECTED DERIVATIVES OF VASOPRESSIN | 1997 |
|
RU2123498C1 |
METHOD FOR OBTAINING ANTIMICROBIAL PEPTIDOMIMETIC | 2022 |
|
RU2804780C1 |
DERIVATIVES OF HEMIN AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD FOR PREPARING, APPLICATION AND PHARMACEUTICAL COMPOSITION | 2002 |
|
RU2238950C2 |
CYCLIC NONAPEPTIDE SHOWING ABILITY TO INHIBIT MYOSIN LIGHT CHAIN KINASE | 2010 |
|
RU2443710C1 |
METHOD FOR PRODUCING A HIGHLY PURIFIED TETRADECAPEPTIDE | 2020 |
|
RU2759377C1 |
PROTECTED DERIVATIVES OF OCTREOTIDE | 2001 |
|
RU2196144C1 |
METHOD OF DIRECTED TRANSPORT OF PHARMACOLOGICAL PREPARATIONS BY THEIR CONJUGATION WITH ARGINYL-GLYCYL-ASPARTYL (RVD)-CONTAINING PEPTIDES | 1996 |
|
RU2119354C1 |
AGENT HAVING ANTIVIRAL ACTIVITY | 2008 |
|
RU2402563C2 |
Authors
Dates
2015-05-10—Published
2014-03-12—Filed